MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review)
- Authors:
- Xindi Liang
- Qiang Wu
- Yuan Wang
- Shirong Li
-
Affiliations: School of Medical Laboratory, Weifang Medical University, Weifang, Shandong 261053, P.R. China, Department of Clinical Laboratory, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China - Published online on: November 14, 2022 https://doi.org/10.3892/or.2022.8445
- Article Number: 8
This article is mentioned in:
Abstract
 |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Pilleron S, Soto-Perez-de-Celis E, Vignat J, Ferlay J, Soerjomataram I, Bray F and Sarfati D: Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer. 148:601–608. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Osmani L, Askin F, Gabrielson E and Li QK: Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 52:103–109. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu G, Cheresh P and Kamp DW: Molecular basis of asbestos-induced lung disease. Annu Rev Pathol. 8:161–187. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Choi WI, Park SH, Park BJ and Lee CW: Interstitial lung disease and lung cancer development: A 5-year nationwide population-based study. Cancer Res Treat. 50:374–381. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Seijo LM and Zulueta JJ: Understanding the links between lung cancer, COPD, and emphysema: A Key to more effective treatment and screening. Oncology (Williston Park). 31:93–102. 2017.PubMed/NCBI | |
|
Ben Amar J, Ben Safta B, Zaibi H, Dhahri B, Baccar MA and Azzabi S: Prognostic factors of advanced stage non-small-cell lung cancer. Tunis Med. 94:360–367. 2016.PubMed/NCBI | |
|
Naylor EC: Adjuvant therapy for stage I and II non-small cell lung cancer. Surg Oncol Clin N Am. 25:585–599. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Liu L and Song X, Wang K, Niu L, Xie L and Song X: TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction. J Cancer Res Clin Oncol. 147:1609–1622. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Maly V, Maly O, Kolostova K and Bobek V: Circulating tumor cells in diagnosis and treatment of lung cancer. In Vivo. 33:1027–1037. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dong X, Chang M and Song X, Ding S, Xie L and Song X: Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer. Thorac Cancer. 12:539–548. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Iqbal MA, Arora S, Prakasam G, Calin GA and Syed MA: MicroRNA in lung cancer: Role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 70:3–20. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34:(Database Issue). D140–D144. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Ren L, Li S, Li W, Zheng X, Yang Y, Fu W, Yi J, Wang J and Du G: The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B. 11:2783–2797. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Huang D and Qu D: Early diagnostic and prognostic value of serum exosomal miR-1246 in non-small cell lung cancer. Int J Clin Exp Pathol. 13:1601–1607. 2020.PubMed/NCBI | |
|
de Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, Åström G, Babina M, Bertin N, Burroughs AM, et al: An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat Biotechnol. 35:872–878. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Solé C and Lawrie CH: MicroRNAs in metastasis and the tumour microenvironment. Int J Mol Sci. 22:48592021. View Article : Google Scholar : PubMed/NCBI | |
|
Di Leva G, Garofalo M and Croce CM: MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Starega-Roslan J, Koscianska E, Kozlowski P and Krzyzosiak WJ: The role of the precursor structure in the biogenesis of microRNA. Cell Mol Life Sci. 68:2859–2871. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Shang R, Baek SC, Kim K, Kim B, Kim VN and Lai EC: Genomic clustering facilitates nuclear processing of suboptimal Pri-miRNA loci. Mol Cell. 78:303–316.e4. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yeom KH, Lee Y, Han J, Suh MR and Kim VN: Characterization of DGCR8/Pasha, the essential cofactor for Drosha in primary miRNA processing. Nucleic Acids Res. 34:4622–4629. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y and Wang X: miRNA-based biomarkers, therapies, and resistance in cancer. Int J Biol Sci. 16:2628–2647. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Alarcón CR, Lee H, Goodarzi H, Halberg N and Tavazoie SF: N6-methyladenosine marks primary microRNAs for processing. Nature. 519:482–485. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Wang Z and Gemeinhart RA: Progress in microRNA delivery. J Control Release. 172:962–974. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Matsuyama H and Suzuki HI: Systems and synthetic microRNA biology: From biogenesis to disease pathogenesis. Int J Mol Sci. 21:1322019. View Article : Google Scholar : PubMed/NCBI | |
|
Haneklaus M, Gerlic M, O'Neill LA and Masters SL: miR-223: Infection, inflammation and cancer. J Intern Med. 274:215–226. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Han L, Yu J, Li H and Li Q: miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis. Aging (Albany NY). 13:10431–10449. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu L, Chen Y, Liu J, Nie K, Xiao Y and Yu H: MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway. Cancer Biomark. 29:347–357. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xiong J, Xing S, Dong Z, Niu L, Xu Q, Li Y, Liu P and Yang P: miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer. Mol Med Rep. 23:1242021. View Article : Google Scholar : PubMed/NCBI | |
|
Du H, Bao Y, Liu C, Zhong A, Niu Y and Tang X: miR-139-5p enhances cisplatin sensitivity in non-small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of homeobox protein Hox-B2. Mol Med Rep. 23:1042021. View Article : Google Scholar : PubMed/NCBI | |
|
Pu R, Pu M, Huang H and Cui Y: MicroRNA 144 inhibits cell migration and invasion and regulates inflammatory cytokine secretion through targeting toll like receptor 2 in non-small cell lung cancer. Arch Med Sci. 17:1028–1037. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan C, Bai R, Gao Y, Jiang X, Li S, Sun W, Li Y, Huang Z, Gong Y and Xie C: Effects of MicroRNA-195-5p on biological behaviors and radiosensitivity of lung adenocarcinoma cells via targeting HOXA10. Oxid Med Cell Longev. 2021:45222102021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Wu G, Zhang H, Peng X, Huang B, Huang M, Ding J, Mao C and Peng C: MiR-196b promotes the invasion and migration of lung adenocarcinoma cells by targeting AQP4. Technol Cancer Res Treat. 20:15330338209858682021. View Article : Google Scholar : PubMed/NCBI | |
|
Fang QY, Deng QF, Luo J and Zhou CC: MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9. Eur Rev Med Pharmacol Sci. 24:2548–2556. 2020.PubMed/NCBI | |
|
Korde A, Jin L, Zhang JG, Ramaswamy A, Hu B, Kolahian S, Guardela BJ, Herazo-Maya J, Siegfried JM, Stabile L, et al: Lung endothelial MicroRNA-1 regulates tumor growth and angiogenesis. Am J Respir Crit Care Med. 196:1443–1455. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ma Z, Wei K, Yang F, Guo Z, Pan C, He Y, Wang J, Li Z, Chen L, Chen Y and Xia Y: Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer. Cell Death Dis. 12:8402021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Cai L, Tian X and Li W: MiR-543 promotes tumorigenesis and angiogenesis in non-small cell lung cancer via modulating metastasis associated protein 1. Mol Med. 26:442020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao G, Zhang Y, Zhao Z, Cai H, Zhao X, Yang T, Chen W, Yao C, Wang Z, Wang Z, et al: MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1. Stem Cell Res Ther. 11:1702020. View Article : Google Scholar : PubMed/NCBI | |
|
Fang L, Cai J, Chen B, Wu S, Li R, Xu X, Yang Y, Guan H, Zhu X, Zhang L, et al: Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling. Nat Commun. 6:86402015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Zhang X, Wang X, He M and Qiao S: MicroRNA-224 promotes tumorigenesis through downregulation of caspase-9 in triple-negative breast cancer. Dis Markers. 2019:73789672019.PubMed/NCBI | |
|
Fassan M, Cui R, Gasparini P, Mescoli C, Guzzardo V, Vicentini C, Munari G, Loupakis F, Lonardi S, Braconi C, et al: miR-224 Is significantly upregulated and targets caspase-3 and caspase-7 during colorectal carcinogenesis. Transl Oncol. 12:282–291. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Liu X, Li C and Wang W: miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma. J Cell Biochem. 120:12412–12421. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Alhazzazi TY, Kamarajan P, Verdin E and Kapila YL: SIRT3 and cancer: Tumor promoter or suppressor? Biochim Biophys Acta. 1816:80–88. 2011.PubMed/NCBI | |
|
Tao F, Gu C, Li N, Ying Y, Feng Y, Ni D, Zhang Q and Xiao Q: SIRT3 acts as a novel biomarker for the diagnosis of lung cancer: A retrospective study. Medicine (Baltimore). 100:e265802021. View Article : Google Scholar : PubMed/NCBI | |
|
Marinov M, Fischer B and Arcaro A: Targeting mTOR signaling in lung cancer. Crit Rev Oncol Hematol. 63:172–182. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhan P, Zhao S, Yan H, Yin C, Xiao Y, Wang Y, Ni R, Chen W, Wei G and Zhang P: α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer. Mol Carcinog. 56:1427–1437. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lu X and Kang Y: Hypoxia and hypoxia-inducible factors: Master regulators of metastasis. Clin Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chen CY, Chen J, He L and Stiles BL: PTEN: Tumor suppressor and metabolic regulator. Front Endocrinol (Lausanne). 9:3382018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang G, Han J, Zhuang L, Li S, Gong Q and Chen Y: Serum starvation induces cell death in NSCLC via miR-224. Onco Targets Ther. 12:3953–3962. 2019.PubMed/NCBI | |
|
Endo M: The roles of ANGPTL families in cancer progression. J UOEH. 41:317–325. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kuo TC, Tan CT, Chang YW, Hong CC, Lee WJ, Chen MW, Jeng YM, Chiou J, Yu P, Chen PS, et al: Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin Invest. 123:1082–1095. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Han H, Pan B, Liang F, Wu L, Liu X, Yang Y and Chen J: MiR-224 promotes lymphatic metastasis by targeting ANGPTL1 in non-small-cell lung carcinoma. Cancer Biomark. 34:431–441. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu JH, De Mello RA, Yan QL, Wang JW, Chen Y, Ye QH, Wang ZJ, Tang HJ and Huang T: MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway. Biochim Biophys Acta Mol Basis Dis. 1866:1657472020. View Article : Google Scholar : PubMed/NCBI | |
|
Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C, Zhou L, Hu Y, Wang Q, Ni S, et al: MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein Cell. 5:851–861. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu G, Lin Y, Zhang H and Wu D: miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Biochem Biophys Res Commun. 463:315–321. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Pan X, Liu W, Chai Y, Wang J and Zhang Y: Genetic and clinical characterization of HOXB2 in glioma. Onco Targets Ther. 13:10465–10473. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Faes S and Dormond O: PI3K and AKT: Unfaithful partners in cancer. Int J Mol Sci. 16:21138–21152. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang L, Cai JL, Huang PZ, Kang L, Huang MJ, Wang L and Wang JP: miR19b-3p promotes the growth and metastasis of colorectal cancer via directly targeting ITGB8. Am J Cancer Res. 7:1996–2008. 2017.PubMed/NCBI | |
|
Li J, Zhu T, Weng Y, Cheng F, Sun Q, Yang K, Su Z and Ma H: Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8. Thorac Cancer. 13:1381–1390. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zhong Y, Zhang C, Liao J and Wang G: PM2.5 downregulates MicroRNA-139-5p and induces EMT in bronchiolar epithelium cells by targeting Notch1. J Cancer. 11:5758–5767. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT and Bremnes RM: Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: Coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer. 116:5676–5685. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liao YC and Lo SH: Tensins-emerging insights into their domain functions, biological roles and disease relevance. J Cell Sci. 134:jcs2540292021. View Article : Google Scholar : PubMed/NCBI | |
|
Duan J, Wang L, Shang L, Yang S, Wu H, Huang Y and Miao Y: miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway. Biosci Rep. 41:BSR202015392021. View Article : Google Scholar : PubMed/NCBI | |
|
Hinsby AM, Berezin V and Bock E: Molecular mechanisms of NCAM function. Front Biosci. 9:2227–2244. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yang B, Huang S, Chen H, Li R, Hou S, Zhao J and Li Y: DNMT3B regulates proliferation of A549 cells through the microRNA-152-3p/NCAM1 pathway. Oncol Lett. 23:112022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Zhou F, Zheng D, Wang D, Li X, Zhao C and Huang X: FGF/FGFR signaling: From lung development to respiratory diseases. Cytokine Growth Factor Rev. 62:94–104. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng Z, Ma R, Tan W and Zhang L: MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2. Exp Mol Med. 46:e1122014. View Article : Google Scholar : PubMed/NCBI | |
|
Zong D, Liu X, Li J, Long Y, Ouyang R and Chen Y: LncRNA-CCAT1/miR-152-3p is involved in CSE-induced inflammation in HBE cells via regulating ERK signaling pathway. Int Immunopharmacol. 109:1088182022. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Lou J, Liu X and Xie Y: LncRNA PCGsEM1 contributes to the proliferation, migration and invasion of non-small cell lung cancer cells via acting as a sponge for miR-152-3p. Curr Pharm Des. 27:4663–4670. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Trakunram K, Chaniad P, Geater SL, Keeratichananont W, Chittithavorn V, Uttayamakul S, Buya S, Raungrut P and Thongsuksai P: Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer. Cancer Biol Med. 17:652–663. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Li Y and Lu J: Identification of circulating miR-762 as a novel diagnostic and prognostic biomarker for non-small cell lung cancer. Technol Cancer Res Treat. 19:15330338209642222020. View Article : Google Scholar : PubMed/NCBI | |
|
Ge P, Cao L, Chen X, Jing R and Yue W: miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer. BMC Cancer. 19:12032019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Zhang Q, Zhang M, Su W, Wang Z, Li Y, Zhang J, Beer DG, Yang S and Chen G: Serum microRNA signature is capable of early diagnosis for non-small cell lung cancer. Int J Biol Sci. 15:1712–1722. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Reis PP, Drigo SA, Carvalho RF, Lopez Lapa RM, Felix TF, Patel D, Cheng D, Pintilie M, Liu G and Tsao MS: Circulating miR-16-5p, miR-92a-3p, and miR-451a in plasma from lung cancer patients: Potential application in early detection and a regulatory role in tumorigenesis pathways. Cancers (Basel). 12:20712020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang HG, Dai CH, Xu YP, Jiang Q, Xia XB, Shu Y and Li J: Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non-small cell lung cancer. Oncol Lett. 22:7922021. View Article : Google Scholar : PubMed/NCBI | |
|
Lu S, Kong H, Hou Y, Ge D, Huang W, Ou J, Yang D, Zhang L, Wu G, Song Y, et al: Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer. Lung Cancer. 123:44–51. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liao J, Shen J, Leng Q, Qin M, Zhan M and Jiang F: MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC). Thorac Cancer. 11:762–768. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xie H and Chen J, Lv X, Zhang L, Wu J, Ge X, Yang Q, Zhang D and Chen J: Clinical value of serum and exhaled breath condensate miR-186 and IL-1β levels in non-small cell lung cancer. Technol Cancer Res Treat. 19:15330338209474902020. View Article : Google Scholar : PubMed/NCBI | |
|
Tulinsky L, Dzian A, Matakova T and Ihnat P: Overexpression of the miR-143/145 and reduced expression of the let-7 and miR-126 for early lung cancer diagnosis. J Appl Biomed. 20:1–6. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Liu F, Li T, Hu P and Dai L: Upregulation of serum miR-629 predicts poor prognosis for non-small-cell lung cancer. Dis Markers. 2021:88199342021.PubMed/NCBI | |
|
Mahmudunnabi RG, Umer M, Seo KD, Park DS, Chung JH, Shiddiky MJA and Shim YB: Exosomal microRNAs array sensor with a bioconjugate composed of p53 protein and hydrazine for the specific lung cancer detection. Biosens Bioelectron. 207:1141492022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Tang Y and Song X, Xie L, Zhao S and Song X: Tumor-derived exosomal miRNAs as diagnostic biomarkers in non-small cell lung cancer. Front Oncol. 10:5600252020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Zhang Y, Yin Y and Li S: Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Pathol Res Pract. 215:1524662019. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 17:1472018. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Z, Wang Z, Sun H and Xin H: Evaluation of exosomal miRNA in Blood as a potential diagnostic biomarker for human non-small cell lung cancer. Med Sci Monit. 26:e9247212020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L and Li Y: Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Oncotarget. 8:13048–13058. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kanaoka R, Iinuma H, Dejima H, Sakai T, Uehara H, Matsutani N and Kawamura M: Usefulness of plasma exosomal MicroRNA-451a as a noninvasive biomarker for early prediction of recurrence and prognosis of non-small cell lung cancer. Oncology. 94:311–323. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Dejima H, Iinuma H, Kanaoka R, Matsutani N and Kawamura M: Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer. Oncol Lett. 13:1256–1263. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Grimolizzi F, Monaco F, Leoni F, Bracci M, Staffolani S, Bersaglieri C, Gaetani S, Valentino M, Amati M, Rubini C, et al: Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression. Sci Rep. 7:152772017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Chen S and Liu B: Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: A Chinese population-based study. Pediatr Surg Int. 32:1059–1065. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Wu LR, Li C, Zhou X, Liu P, Jia X, Chen Y and Zhu W: Five serum microRNAs for detection and predicting of ovarian cancer. Eur J Obstet Gynecol Reprod Biol X. 3:1000172019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Q, Yu L, Lin X, Zheng Q, Zhang S, Chen D, Pan X and Huang Y: Combination of serum miRNAs with serum exosomal miRNAs in early diagnosis for non-small-cell lung cancer. Cancer Manag Res. 12:485–495. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Shan W, Hong B, Zou J, Li H, Han D, Zhang Y, Li L, Li D and Lin W: Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer. Sci Rep. 10:127052020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao YL, Zhang JX, Yang JJ, Wei YB, Peng JF, Fu CJ, Huang MH, Wang R, Wang PY, Sun GB and Xie SY: MiR-205-5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer. Thorac Cancer. 13:832–843. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Jiang X, Li J, Wang J, Binang H, Shi S, Duan W, Zhao Y and Zhang Y: Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer. Thorac Cancer. 11:3436–3447. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou C, Chen Z, Zhao L, Zhao W, Zhu Y, Liu J and Zhao X: A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer. J Clin Lab Anal. 34:e235052020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Jia Y, Xiao Y, Hao Y, Zhang L, Chen X, He J, Zhao Y and Qian Z: Tumor-targeting anti-MicroRNA-155 delivery based on biodegradable poly(ester amine) and hyaluronic acid shielding for lung cancer therapy. Chemphyschem. 19:2058–2069. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, et al: Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin Cancer Res. 23:5311–5319. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Migdalska-Sęk M, Modrzewska B, Kordiak J, Pastuszak-Lewandoska D, Kiszałkiewicz JM, Bielec F, Antczak A and Brzeziańska-Lasota E: Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer. Sci Rep. 11:241362021. View Article : Google Scholar : PubMed/NCBI |
